Dual epitope anti-LILRB4 synthetic T-cell receptor and antigen receptor (STAR)-T-cell therapy for relapsed/refractory acute myeloid leukemia

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02765-7|IF:81.2

Spatiotemporally programmed nanomedicine engineering to resolve conflicting immunosignals in triple-negative breast cancer

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02685-6|IF:81.2

CHPO coordinates chilling recovery and nitrogen use in rice

Journal:NATURE|DOI:10.1038/s41586-026-10682-6|IF:56.1

Tumor cells metabolically resist immune-checkpoint therapy by macrophage efferocytosis-mediated fatty acid recycling

Journal:CANCER CELL|DOI:10.1016/j.ccell.2026.05.005|IF:56.1

Single-cell identifies and validates human circulating Treg subtype/state Tregfci in non-small cell lung cancer

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02677-6|IF:52.7

Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02680-x|IF:52.7

Investigating the effects and underlying mechanisms of glycosylation sites on the immunogenicity of COVID-19 vaccines

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02751-z|IF:52.7

Disrupting SOX2 self-association and condensate formation to overcome chemotherapeutic drug resistance in lung squamous cell carcinoma

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02696-3|IF:52.7

Conductive coordination nanozyme prodrugs precisely trigger pyroptosis, cuproptosis and ferroptosis for in situ cancer vaccination

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02607-6|IF:52.7

Thromboxane receptor activation in dendritic cells mitigates sepsis by suppressing S100a8/a9-mediated neutrophil recruitment

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02592-w|IF:52.7

Unleashing the potential of bimetallic nanobomb-mediated STING pathway to enhance bispecific T-cell engager against colorectal cancer photo-immunotherapy

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02596-6|IF:52.7

A biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptoms

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02640-5|IF:52.7

BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axis

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02644-1|IF:52.7

Molecular mechanism of cholesterol-dependent membrane fusion in SARS-CoV-2 entry

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02573-z|IF:52.7

VCPIP1 drives diabetic cardiomyopathy by deubiquitinating AMPKγ1 and preventing AMPKα-γ subunit assembly in cardiomyocytes

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02701-9|IF:52.7

Targeting ZMIZ1 induces differentiation in acute myeloid leukemia via chromatin remodeling

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-026-02766-6|IF:52.7

Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform

Journal:Signal Transduction and Targeted Therapy|DOI:10.1038/s41392-025-02542-y|IF:52.7